📰 Code Therapeutics News
Page 8 - Code Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Code Therapeutics. Real-time updates on events, politics, business and more.
April 6, 2023
Gainers Liquid Media Group Ltd. (NASDAQ:YVR) jumped 88.1% to $0.2719. Clean Energy Technologies, Inc. (NASDAQ:CETY) surged 47% to $3.44. Clean E...
April 5, 2023
BOSTON, April 05, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been... | April 5, 2023
March 31, 2023
BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023
March 31, 2023
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | March 31, 2023
March 29, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 263,500 shares, a decrease of 51.3% from the February 28th total of 541,400 shares. Currently, 2.3% of the company’s stock are short sold. Based on an average […]
March 24, 2023
Latest news on Messenger RNA (mRNA), a type of RNA that is necessary for protein production, which can be used to treat disease or function as a vaccine.
March 15, 2023
– Phase 1 trial to evaluate safety and tolerability of a single ascending dose of RCT1100, an inhaled mRNA-based genetic medicine– First clinical-stage candidate from ReCode’s proprietary SORT LNP delivery platform designed to restore ciliary function in the lungs of people with PCD caused by pathogenic mutations in...
February 18, 2023
BOSTON, Feb. 17, 2023 -- TransCode Therapeutics, Inc. , an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing of its previously... | February 17, 2023
February 2, 2023
Recode Therapeutics Expands Leadership Team with Appointment of April Loui as Senior Vice President of Quality and CMC Regulatory Affairs - read this article along with other careers information, tips and advice on BioSpace
January 10, 2023
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that it has signed a multi-year research collaboration and option agreement with ReCode Therapeutics. Under this agreement, the companies will work together to potentially discover precision ...